Hyundai Mobis Co. has come up with an in-house brainwave-based driver monitoring system that can reduce the risk of drowsy driving by up to one-third.
The system, dubbed M.Brain, is a wearable earpiece that continuously detects and analyzes drivers' brain activity.
The company has examined the actual effect of the technology through a pilot study on public buses in Gyeonggi Province over the past year in partnership with the Gyeonggi Research Institute.
According to the findings, drivers who used M.Brain saw their risk of careless driving during after-meal hours, when drowsy driving is most common, drop by up to 30 percent.
M.Brain helped minimize the danger of careless driving by roughly 20% on highways where drowsy driving can lead to multi-car accidents.
When sloppy driving was detected in real-time, the device helped drivers recover attention within 2.3 seconds by blasting an alarm over the speakers and vibrating the seat.
This is nearly three times faster than the 6.7 seconds it took non-M.Brain drivers to regain attention.


Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Neuralink Expands Brain Implant Trials with 12 Global Patients
Tabletop particle accelerator could transform medicine and materials science
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 



